Okuno H, Kakehi Y, Ozdemir E, Terachi T, Okada Y, Yoshida O
Department of Urology, Faculty of Medicine, Kyoto University, Japan.
J Urol. 1997 Nov;158(5):1996-9. doi: 10.1016/s0022-5347(01)64200-9.
One problem in the treatment of urothelial cancers, in particular of upper urinary tract cancers, is multifocal synchronous and/or metachronous tumor development in the heterotopic urothelium. We investigated the abilities of exfoliated cells in the urine of patients with urothelial cancers to colonize and proliferate in vitro.
Short-term cultures of 129 urine samples obtained from patients with urothelial cancers and 53 samples from healthy volunteers were compared as to the growth potential of urinary-exfoliated cells and clinico-pathological features, in particular tumor localization and evidence of intraluminal tumor recurrence.
Primary cell outgrowth occurred in 112 (86.8%) of the 129 cell cultures from the patients and in 29 (54.7%) of the 53 from the healthy volunteers (p < 0.0001). "Sufficient cell growth" (more than 10(5) cells per flask) was obtained for 77 (59.7%) of the 129 cultures from patients and 7 (13.2%) of the 53 from the healthy volunteers (p < 0.0001). In terms of tumor localization, the rate of sufficient cell growth was significantly higher for patients with upper urinary tract tumor (21/25, 84.0%) than for those with bladder tumor (56/104, 53.8%) (p = 0.0062). Proportional hazard regression analysis showed that only the growth potential of the urinary-exfoliated cells was significantly predictive of intravesical tumor recurrence in patients with superficial bladder tumors (p = 0.011).
The potentials for the colonization and proliferation of urinary-exfoliated cells are associated with intraluminal multifocal tumor recurrence of urothelial cancers.
尿路上皮癌,尤其是上尿路癌治疗中的一个问题是异位尿路上皮中多灶性同步和/或异时性肿瘤的发生。我们研究了尿路上皮癌患者尿液中脱落细胞在体外的定植和增殖能力。
比较了从尿路上皮癌患者获得的129份尿液样本和53份健康志愿者样本的短期培养物,以观察尿脱落细胞的生长潜力及临床病理特征,特别是肿瘤定位和腔内肿瘤复发的证据。
129例患者的细胞培养物中有112例(86.8%)出现原代细胞生长,53例健康志愿者的细胞培养物中有29例(54.7%)出现原代细胞生长(p<0.0001)。129例患者的培养物中有77例(59.7%)实现了“足够的细胞生长”(每瓶超过10⁵个细胞),53例健康志愿者的培养物中有7例(13.2%)实现了“足够的细胞生长”(p<0.0001)。就肿瘤定位而言,上尿路肿瘤患者的足够细胞生长率(21/25,84.0%)显著高于膀胱肿瘤患者(56/104,53.8%)(p=0.0062)。比例风险回归分析显示,只有尿脱落细胞的生长潜力对浅表性膀胱肿瘤患者的膀胱内肿瘤复发具有显著预测性(p=0.011)。
尿脱落细胞的定植和增殖潜力与尿路上皮癌的腔内多灶性肿瘤复发相关。